Brinkhuizen, Tjinta <br/><br/>
The effect of topical diclofenac 3% and calcitriol 3 μg/g on superficial basal cell carcinoma (sBCC) and nodular basal cell carcinoma (nBCC): A phase II, randomized controlled trial.  [electronic resource] 

 -  Journal of the American Academy of Dermatology  Jul 2016 
 - 126-34 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1097-6787 
<br/><br/><label>Standard No.: </label>10.1016/j.jaad.2016.01.050  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Topical<br/>Aged<br/>Anti-Inflammatory Agents, Non-Steroidal--administration & dosage<br/>Apoptosis--drug effects<br/>Calcitriol--administration & dosage<br/>Carcinoma, Basal Cell--chemistry<br/>Cell Proliferation--drug effects<br/>Diclofenac--administration & dosage<br/>Drug Therapy, Combination<br/>Female<br/>Gels<br/>Humans<br/>Ki-67 Antigen--analysis<br/>Male<br/>Medication Adherence<br/>Middle Aged<br/>Ointments<br/>Proto-Oncogene Proteins c-bcl-2--analysis<br/>Single-Blind Method<br/>Skin Neoplasms--chemistry<br/>Treatment Outcome<br/>Vitamins--administration & dosage